BioCorRx Inc.
BICX
$0.44
$0.0410.25%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 32.10% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 32.10% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 32.10% | -- | |||
| SG&A Expenses | 38.05% | 5.59% | |||
| Depreciation & Amortization | 190.32% | 90.77% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 48.42% | -4.61% | |||
| Operating Income | -50.75% | 16.61% | |||
| Income Before Tax | -61.69% | 30.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -61.69% | 30.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 1,283.65% | -83.49% | |||
| Net Income | -46.59% | 27.75% | |||
| EBIT | -50.75% | 16.61% | |||
| EBITDA | -46.96% | 17.86% | |||
| EPS Basic | -30.16% | 39.19% | |||
| Normalized Basic EPS | -37.80% | 45.51% | |||
| EPS Diluted | -30.16% | 39.19% | |||
| Normalized Diluted EPS | -37.80% | 45.51% | |||
| Average Basic Shares Outstanding | 12.70% | 18.68% | |||
| Average Diluted Shares Outstanding | 12.70% | 18.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||